B
Bioscience Animal Health PCL
SET:BIS
Bioscience Animal Health PCL
SET:BIS
Price:
2.06
THB
Market Closed
Market Cap:
฿646.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
B
|
Bioscience Animal Health PCL
SET:BIS
|
TH |
|
C
|
Coral India Finance and Housing Ltd
NSE:CORALFINAC
|
IN |
|
U
|
United Hunter Oil & Gas Corp
XTSX:UHO
|
CA |
|
A
|
Aesthetic Connect PCL
SET:TRP
|
TH |
|
Yantai Ishikawa Sealing Technology Co Ltd
SZSE:301020
|
CN |
|
Nanjing Red Sun Co Ltd
SZSE:000525
|
CN |
|
P
|
Proud Real Estate PCL
SET:PROUD
|
TH |
|
B
|
Bluedon Information Security Technologies Co Ltd
SZSE:300297
|
CN |
|
I
|
Interlink Telecom PCL
SET:ITEL
|
TH |
|
Zhejiang Huada New Materials Co Ltd
SSE:605158
|
CN |
Balance Sheet
Balance Sheet Decomposition
Bioscience Animal Health PCL
Bioscience Animal Health PCL
Balance Sheet Decomposition is not available for
Bioscience Animal Health PCL
Bioscience Animal Health PCL
Balance Sheet
Bioscience Animal Health PCL
Bioscience Animal Health PCL
Currency: THB
| Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
26
|
72
|
22
|
25
|
128
|
|
| Cash Equivalents |
26
|
72
|
22
|
25
|
128
|
|
| Short-Term Investments |
0
|
0
|
104
|
72
|
55
|
|
| Total Receivables |
413
|
408
|
421
|
505
|
501
|
|
| Accounts Receivables |
400
|
387
|
417
|
499
|
483
|
|
| Other Receivables |
13
|
21
|
4
|
6
|
18
|
|
| Inventory |
176
|
226
|
279
|
349
|
265
|
|
| Other Current Assets |
12
|
13
|
23
|
72
|
70
|
|
| Total Current Assets |
627
|
720
|
848
|
1 024
|
1 019
|
|
| PP&E Net |
116
|
125
|
121
|
122
|
125
|
|
| PP&E Gross |
116
|
125
|
121
|
122
|
125
|
|
| Accumulated Depreciation |
68
|
64
|
74
|
84
|
97
|
|
| Intangible Assets |
2
|
2
|
4
|
6
|
6
|
|
| Note Receivable |
10
|
6
|
0
|
8
|
27
|
|
| Long-Term Investments |
34
|
38
|
63
|
21
|
28
|
|
| Other Long-Term Assets |
25
|
27
|
47
|
47
|
47
|
|
| Total Assets |
815
N/A
|
919
+13%
|
1 085
+18%
|
1 228
+13%
|
1 253
+2%
|
|
| Liabilities | ||||||
| Accounts Payable |
299
|
304
|
276
|
383
|
322
|
|
| Accrued Liabilities |
19
|
14
|
13
|
23
|
34
|
|
| Short-Term Debt |
183
|
255
|
0
|
0
|
44
|
|
| Current Portion of Long-Term Debt |
31
|
18
|
3
|
3
|
5
|
|
| Other Current Liabilities |
22
|
15
|
12
|
14
|
15
|
|
| Total Current Liabilities |
554
|
606
|
304
|
424
|
420
|
|
| Long-Term Debt |
42
|
39
|
4
|
4
|
7
|
|
| Minority Interest |
2
|
1
|
8
|
11
|
12
|
|
| Other Liabilities |
6
|
7
|
9
|
10
|
11
|
|
| Total Liabilities |
600
N/A
|
654
+9%
|
324
-50%
|
448
+38%
|
450
+0%
|
|
| Equity | ||||||
| Common Stock |
110
|
110
|
157
|
157
|
157
|
|
| Retained Earnings |
101
|
151
|
98
|
117
|
145
|
|
| Additional Paid In Capital |
0
|
0
|
502
|
502
|
502
|
|
| Unrealized Security Profit/Loss |
4
|
4
|
4
|
4
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
1
|
|
| Total Equity |
215
N/A
|
265
+23%
|
761
+187%
|
780
+2%
|
802
+3%
|
|
| Total Liabilities & Equity |
815
N/A
|
919
+13%
|
1 085
+18%
|
1 228
+13%
|
1 253
+2%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
314
|
314
|
314
|
314
|
314
|
|
Switch to:
Switch to:
See Also
Discover More
